Health Minister Brad Hazzard
said research has the potential
to deliver a new care
model, therapies and better outcomes for
children with in-operable brain tumors.
“Despite significant advances in childhood cancer treatments, the
prognosis for kids battling aggressive brain cancers worldwide remains bleak,”
Mr Hazzard said.
“The NSW Government, through the Cancer Institute NSW has invested more
than $16 million over the last five years in paediatric cancer research.
“In addition, Australia’s first Comprehensive
Children’s Cancer Centre will be built at the Sydney Children’s
Hospital by the NSW
Government with an investment of $608 million.
“The latest funding boost
for researchers will hopefully help get new treatments from the laboratory benchtop to the bedside
much quicker, giving some hope
Brain tumours are the most common form of solid tumours among children.
Malignant brain tumours kill more children in Australia than any other disease.
Associate Professor David Ziegler of
the Sydney Children’s Hospital, Randwick received a Translational
Program Grant of
$3.75 million to develop new treatments
for diffuse intrinsic pontine glioma (DIPG),
presently an inoperable brain stem tumour in children.
“With this additional funding, we’ll be looking
at treatments like immunotherapy
and drugs targeting specific genetic mutations
to help our young
patients,” Professor Ziegler said.
Also announced as
part of today’s funding was $3.3 million in Cancer Research Fellowships
supporting early and mid-career researchers.
Professor David Currow, Chief Cancer Officer and CEO of
the Cancer Institute NSW, administered the funding. He said the Fellowships
formed a vital part of NSW’s research investment.
“Investing in our researchers
at the beginning of their careers, helps ensure NSW remains
at the forefront of cancer research, delivering better outcomes for all patients.”
For more information http://bit.ly/CINSWtranslationalprogramgrants